medigraphic.com
Anales de Otorrinolaringología Mexicana

2015, Number 2

Next >>

Otorrinolaringología 2015; 60 (2)

Comparison between intratympanic application and systemic administration of steroid for the treatment of patients with sudden hearing loss

De la Garza-Hesles H, Camacho-Rivera CI, Esteinou-Madrid C

Language: Spanish
References: 22
Page: 61-68
PDF size: 380.53 Kb.


ABSTRACT

Background: For the treatment of patients with sudden hearing loss, the use of steroids has being established as the procedure of choice. Objective: To compare the efficacy of prescription of intratympanic vs systemic steroid administration as initial treatment in patients with sudden hypoacusia.
Material and method: A retrospective, descriptive and observational study including 17 patients with intratympanic administration of steroid (ITE). For each patient from this group, two patients from the same age group were selected for the systemic steroid group (SE).
Results: It was found that 13 of 17 of the ITE patients, and 23 of 34 of the SE patients had hearing improvement; for an overall of 6 and 9 patients, respectively. No improvements were observed in the subsequent hearing tests in 4 of 17 of the cases with ITE, and 11 of 34 with SE. In both groups there was greater hearing gain on the lower frequencies. Subsequent to the statistical analysis, no significant differences were found for the variables of gender, laterality, time of the beginning of treatment, or associated symptoms. With regards to the age group, a larger hearing gain was observed in young patients, and worse prognosis in patients older than 60 years in both groups. There were no complications in the short or long term in ITE patients in this series.
Conclusions: Administration of intratympanic steroid as first-line treatment compared to conventional treatment of systemic administration, showed to be a procedure with good results for auditory recovery with low morbidity, because in the series there were not short- or long-term adverse effects, such as tympanic perforations or vertigo.


REFERENCES

  1. Tsai YJ, Liang JG, Wu WB, et al. Intratympanic injection with dexamethasone for sudden sensorineural hearing loss. J Laryngol Otol 2011;125:133-137.

  2. Stachler R, Chandrasekhar SS, Archer SM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg 2012;1-35.

  3. Haynes DS, O’Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Layngoscope 2007;117:3-15.

  4. Ahn JH, Yoo MH, Yoon TH, et al. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients whit sudden deafness. Laryngoscope 2008;118:279-282.

  5. Slattery WH, Fisher LM, Iqbal Z, et al. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg 2005;133:251-259.

  6. RauchSD, Halpin CF, Antonelli PJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA 2011;305:2071- 2079.

  7. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2008;29:453-460.

  8. Park MK, Lee CK, Park KH, et al. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2011;145:1016-1021.

  9. Spear S, Schwartz S. Intratympanic steroids for sudden sensorineural hearing loss: a systematic review. Otolaryngol Head Neck Surg 2011;145:534-543.

  10. Han CS, Park JR, Boo SH, Jo JM, et al. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg 2009;141:572-578.

  11. Seggas I, Koltsidopoulos P, Bibas A. Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol 2011;32:29-35.

  12. Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment: A review. Otol Neurotol 2004;25:1034-1039.

  13. Rauch SD. Intratympanic steroids for sensorineural hearing loss. Otolaryngologic Clin North Am 2004;37:1061-1074.

  14. Filipo R, Covelli E, Balsamo G, Attanasio G. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: A new protocol. Acta Otolaryngol 2010;130:1209- 1213.

  15. Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol 2005;26:878-881.

  16. Kara E, Cetik F, Tarkan O, Sürmelioglu O. Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2010;267:701- 707.

  17. Xenellis J, Papadimitriou N, Nikolopoulos T, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg 2006;134:940-945.

  18. Wu HP, Chou YF, Yu SH, Wang CP, et al. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study. Otol Neurotol 2011;32:774-779.

  19. Khaimook W, Jantarapattana K. Therapy of idiopathic sudden sensorineural hearing loss with intratympanic steroid injection 2011;94:1495-1499.

  20. Lee JB, Choi SJ, Park K, Park HY, et al. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2011;268:833-839.

  21. She W, Dai Y, Du X, Yu C, et al. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2010;142:266-271.

  22. Wei BP, Mubiru S, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006;25:CD003998.




2020     |     www.medigraphic.com